Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights
Heba A. Elsebaie, Eman A. El-Bastawissy, Kamel M. Elberembally, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106799-106799
Closed Access | Times Cited: 23

Showing 23 citing articles:

Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities
Heba A. Elsebaie, Tarek F. El‐Moselhy, Eman A. El-Bastawissy, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107101-107101
Closed Access | Times Cited: 13
Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Haytham O. Tawfik, Mohamed M. Saleh, Andrea Ammara, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1611-1623
Closed Access | Times Cited: 13
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7406-7430
Closed Access | Times Cited: 6
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116527-116527
Closed Access | Times Cited: 6
Novel imidazo[2,1-b]thiazoles and imidazo[1,2-a]pyridines tethered with indolinone motif as VEGFR-2 inhibitors and apoptotic inducers: Design, synthesis and biological evaluations
Mahmoud S. Elkotamy, Mohamed K. Elgohary, Sara T. Al‐Rashood, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107644-107644
Closed Access | Times Cited: 6
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 5
Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments
Heba A. Elsebaie, Maha-Hamadien Abdulla, Zainab M. Elsayed, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107626-107626
Closed Access | Times Cited: 5
Design, synthesis, molecular docking and dynamic studies of novel thienopyrimidine analogs linked to 1,2,3-triazole-bearing acetamide derivatives as anti-oxidant agents
Tammineni Lalita Kumari, Alice R. Robert, Prashantha Karunakar, et al.
Journal of Molecular Structure (2024) Vol. 1307, pp. 137883-137883
Closed Access | Times Cited: 4
Synthesis and biological evaluation of 1-phenyl-tetrahydro-β-carboline-based first dual PRMT5/EGFR inhibitors as potential anticancer agents
Juan Zhang, Xuliang Liu, Na Sa, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116341-116341
Closed Access | Times Cited: 4
Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors
Wagdy M. Eldehna, Zainab M. Elsayed, Andrea Ammara, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135010-135010
Closed Access | Times Cited: 4
EGFR as therapeutic target to develop new generation tyrosine kinase inhibitors against breast cancer: A critical review
Ruby Mariam Raju, Jeffin Joy A, Raghavendra Nulgumnalli Manjunathaiah, et al.
Results in Chemistry (2024) Vol. 7, pp. 101490-101490
Open Access | Times Cited: 3
Tailored horseshoe-shaped nicotinonitrile scaffold as dual promising c-Met and Pim-1 inhibitors: Design, synthesis, SAR and in silico study
Samy Mohamady, Ahmed Khalil, Bassem H. Naguib, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106988-106988
Closed Access | Times Cited: 9
A decade's overview of 2‐aminothiophenes and their fused analogs as promising anticancer agents
Donia G. Darwish, Hany A.M. El-Sherief, Salah A. Abdel‐Aziz, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 6
Closed Access | Times Cited: 2
DFT and molecular simulation validation of the binding activity of PDEδ inhibitors for repression of oncogenic k-Ras
Taghreed A. Majrashi, Ahmed Sabt, Hadia Almahli, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0300035-e0300035
Open Access | Times Cited: 2
Discovery of new quinoline derivatives bearing 1-aryl-1,2,3-triazole motif as influenza H1N1 virus neuraminidase inhibitors
Ahmed Sabt, Eman F. Khaleel, Moataz A. Shaldam, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107703-107703
Closed Access | Times Cited: 2
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 2
Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors
Mohammed Hawash
Cells (2024) Vol. 13, Iss. 19, pp. 1656-1656
Open Access | Times Cited: 2
Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studies
Heba A. Elsebaie, Mohamed S. Nafie, Haytham O. Tawfik, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2553-2569
Closed Access | Times Cited: 1
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22132-22146
Open Access | Times Cited: 1
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents
Bassem H. Naguib, Heba A. Elsebaie, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107682-107682
Closed Access | Times Cited: 1
Muti-target rationale design of novel substituted N-phenyl-2-((6-phenylpyridazin-3-yl)thio)acetamide candidates as telomerase/JAK1/STAT3/TLR4 inhibitors: In vitro and in vivo investigations
Moataz A. Shaldam, Mai H. A. Mousa, Haytham O. Tawfik, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107843-107843
Closed Access | Times Cited: 1
One‐Pot Three‐Component Construction of 2,4‐Diarylbenzo[4,5] thieno[3,2‐d] pyrimidines Using Elemental Sulfur as a Sulfur Source
Guorui Li, Fei Wen, Zheng Li
ChemistrySelect (2024) Vol. 9, Iss. 23
Closed Access
Advances in structural identification of some thieno[2,3-d]pyrimidine scaffolds as antitumor molecules: Synthetic approaches and control programmed cancer cell death potential
Aml E.-S. Mghwary, Rasha A. Hassan, Peter A. Halim, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107985-107985
Closed Access
Page 1

Scroll to top